Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery
Launched by DUKE UNIVERSITY · Jul 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how extra protein in the diet can help older adults who have experienced serious injuries recover better in the hospital and after they go home. The trial will compare two groups of patients: one group will receive extra protein supplements three times a day while in the hospital and for four weeks after discharge, while the other group will receive standard nutrition advice from their healthcare team. Both groups will undergo tests to measure their energy use and changes in body composition, which includes muscle mass.
To be eligible for this trial, participants must be at least 45 years old and have come to the emergency department with a serious injury. They should also be able to take nutrition by mouth and have had a CT scan during their hospital stay. However, patients who are on life support, have certain types of injuries, or are pregnant cannot participate. This trial aims to find out if enhanced nutrition can support recovery in trauma patients, which could lead to improved outcomes for individuals facing similar health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are at least 45 years old and presented to the Emergency Department as a leveled trauma
- • Patients who have the ability to tolerate oral nutrition
- • Patients who have had a standard of care CT scan this admission
- Exclusion Criteria:
- • Expected withdrawal of life-sustaining treatment within 48 hours
- • Traumatic Brain Injury
- • Presence of lower extremity fracture(s)
- • Mechanical Ventilation
- • Subjects for who the Investigator would recommend a different supplement based on their medical condition.
- • Prisoner
- • Pregnancy for women of child-bearing potential
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Paul Wischmeyer, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported